These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 9864917

  • 1. Disappearance of PML/RAR alpha acute promyelocytic leukemia-associated transcript during consolidation chemotherapy.
    Martinelli G, Ottaviani E, Testoni N, Visani G, Diverio D, D'Elia G, Mandelli F, Tura S.
    Haematologica; 1998 Nov; 83(11):985-8. PubMed ID: 9864917
    [Abstract] [Full Text] [Related]

  • 2. Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy.
    Breccia M, Diverio D, Noguera NI, Visani G, Santoro A, Locatelli F, Damiani D, Marmont F, Vignetti M, Petti MC, Lo Coco F.
    Haematologica; 2004 Jan; 89(1):29-33. PubMed ID: 14754603
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients.
    Gameiro P, Vieira S, Carrara P, Silva AL, Diamond J, Botelho de Sousa A, Mehta AB, Prentice HG, Guimarães JE, Hoffbrand AV, Foroni L, Parreira A.
    Haematologica; 2001 Jun; 86(6):577-85. PubMed ID: 11418366
    [Abstract] [Full Text] [Related]

  • 6. PML-RAR alpha fusion transcripts by RNA PCR in acute promyelocytic leukemia in remission and its correlation with clinical outcome.
    Ikeda K, Sasaki K, Tasaka T, Nagai M, Kawanishi K, Takahara J, Irino S.
    Int J Hematol; 1994 Oct; 60(3):197-205. PubMed ID: 7858239
    [Abstract] [Full Text] [Related]

  • 7. Diagnosis and follow-up of acute promyelocytic leukemia by detection of PML-RAR alpha gene rearrangement.
    Gau JP, Young JH, Lin TH, Yang YS.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):175-81. PubMed ID: 10746412
    [Abstract] [Full Text] [Related]

  • 8. Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: clinicopathological and molecular features of a pilot study.
    Kwong YL, Au WY, Chim CS, Pang A, Suen C, Liang R.
    Am J Hematol; 2001 Apr; 66(4):274-9. PubMed ID: 11279639
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term disease-free acute promyelocytic leukemia patients really can be cured at molecular level.
    Martinelli G, Ottaviani E, Visani G, Testoni N, Montefusco V, Tura S.
    Haematologica; 1998 Sep; 83(9):860-3. PubMed ID: 9825588
    [Abstract] [Full Text] [Related]

  • 14. Role of autologous bone marrow transplantation as consolidation therapy in acute promyelocytic leukemia patients in complete remission.
    Ottaviani E, Martinelli G, Testoni N, Visani G, Tani M, Tura S.
    Haematologica; 1998 Nov; 83(11):1051-5. PubMed ID: 9864933
    [Abstract] [Full Text] [Related]

  • 15. Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups.
    Mandelli F, Diverio D, Avvisati G, Luciano A, Barbui T, Bernasconi C, Broccia G, Cerri R, Falda M, Fioritoni G, Leoni F, Liso V, Petti MC, Rodeghiero F, Saglio G, Vegna ML, Visani G, Jehn U, Willemze R, Muus P, Pelicci PG, Biondi A, Lo Coco F.
    Blood; 1997 Aug 01; 90(3):1014-21. PubMed ID: 9242531
    [Abstract] [Full Text] [Related]

  • 16. [Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia].
    Xu XJ, Shi SW, Tang YM, Song H, Yang SL, Wei J, Xu WQ, Pan BH, Chen YH, Zhao FY, Shen HQ, Qian BQ, Zhang LY, Ning BT.
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb 01; 9(1):28-33. PubMed ID: 17306073
    [Abstract] [Full Text] [Related]

  • 17. All-transretinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia.
    Al Bahar S, Pandita R, Bavishi K, Kreze O.
    Indian J Cancer; 2004 Feb 01; 41(3):125-8. PubMed ID: 15472411
    [Abstract] [Full Text] [Related]

  • 18. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia.
    Raza S, Ullah K, Ahmed P, Khan B.
    J Coll Physicians Surg Pak; 2008 Sep 01; 18(9):546-50. PubMed ID: 18803891
    [Abstract] [Full Text] [Related]

  • 19. Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols.
    Mandelli F, Latagliata R, Avvisati G, Fazi P, Rodeghiero F, Leoni F, Gobbi M, Nobile F, Gallo E, Fanin R, Amadori S, Vignetti M, Fioritoni G, Ferrara F, Peta A, Giustolisi R, Broccia G, Petti MC, Lo-Coco F, Italian GIMEMA Cooperative Group.
    Leukemia; 2003 Jun 01; 17(6):1085-90. PubMed ID: 12764372
    [Abstract] [Full Text] [Related]

  • 20. [Long-term therapeutic outcome of patients with acute promyelocytic leukemia].
    Zhang L, Li R, Li DP, Liu YZ, Xu SC, Hao YS, Xiao ZJ.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jan 01; 28(1):15-8. PubMed ID: 17649719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.